References
- Baynes JW. (1991). Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–12
- Cavaghan MK, Ehrmann DA, Polonsky KS. (2000). Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 106:329–33
- Chatuphonprasert W, Nemoto N, Sakuma T, Jarukamjorn K. (2012). Modulations of cytochrome P450 expression in diabetic mice by berberine. Chem Biol Interact 196:23–9
- Chatuphonprasert W, Sangkawat T, Nemoto N, Jarukamjorn K. (2011). Suppression of beta-naphthoflavone induced CYP1A expression and lipid-peroxidation by berberine. Fitoterapia 82:889–95
- Chatuphonprasert W, Udomsuk L, Monthakantirat O, et al. (2013). Effects of Pueraria mirifica and miroestrol on the antioxidation-related enzymes in ovariectomized mice. J Pharm Pharmacol 65:447–56
- Lao-ong T, Chatuphonprasert W, Nemoto N, Jarukamjorn K. (2012). Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine. Pharm Biol 50:1007–12
- Likidlilid A, Patchanans N, Poldee S, Peerapatdit T. (2007). Glutathione and glutathione peroxidase in type 1 diabetic patients. J Med Assoc Thailand 90:1759–67
- Liu W, Hei Z, Nie H, et al. (2008). Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J 121:706–12
- Maritim AC, Sanders RA, Watkins JB. (2003). Diabetes, oxidative stress, and antioxidants: A review. Biochem Mol Toxicol 17:24–38
- Matsuyama-Yokono A, Tahara A, Nakano R, et al. (2009). Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin--nicotinamide-induced mildly diabetic mice. Metab Clin Exper 58:379–86
- Morel Y, Barouki R. (1999). Repression of gene expression by oxidative stress. Biochem J 342:481–96
- Mouatassim S, Guerin P, Menezo Y. (1999). Expression of genes encoding antioxidant enzymes in human and mouse oocytes during the final stages of maturation. Mol Human Reprod 5:720–5
- Piconi L, Quagliaro L, Ceriello A. (2003). Oxidative stress in diabetes. Clin Chem Lab Med 41: 1144–9
- Piyanuch P, Gritsanapan W, Suntornsuk L. (2006). Determination of berberine content in the stem extracts of Coscinium fenestratum by TLC densitometry. Med Princ Pract 15:373–8
- Punitha ISR, Shirwaikar A, Shirwaikar A. (2005). Antidiabetic activity of benzyl tetra isoquinoline alkaloid berberine in streptozotocin--nicotinamide induced type 2 diabetic rats. Diabetologia Croatica 34:117–28
- Reed MJ, Meszaros K, Entes LJ, et al. (2000). A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat. Metabolism 49:1390–4
- Sakuma T, Honnia R, Maguchi S, et al. (2001). Different expression of hepatic and renal cytochrome P450s between the streptozotocin induced diabetic mouse and rat. Xenobiotica 31:223–37
- Sato F, Yamada Y. (1984). High berberine-producing cultures of Coptis japonica cells. Phytochemistry 23:281–5
- Sharma N, Garg V. (2009). Antidiabetic and antioxidant potential of ethanolic extract of Butea monosperma leaves in alloxan-induced diabetic mice. Indian J Biochem Biophys 46:99–105
- Szkudelski T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:536–46
- Tang LQ, Wei W, Chen LM, Liu S. (2006). Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 108:109–15
- Wang Y, Campbell T, Perry B, et al. (2010). Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism 60:298–305
- West IC. (2000). Radicals and oxidative stress in diabetes. Diabetes Med 17:171–80
- Zelko IN, Mariani TJ, Folz RJ. (2002). Superoxide dismutase multigene family: A comparison of the CuZn-Sod (Sod1), Mn-Sod (Sod2), and Ec-Sod (Sod3) gene structures, evolution, and expression. Free Radical Biol Med 33:337–49
- Zhang Y, Li X, Zou D, et al. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 93:2559–65
- Zhang Q, Xiao X, Feng K, et al. (2011). Berberine moderates glucose and lipid metabolism through multi pathway mechanism. Evid Based Complement Alternat Med 2011:1–10